v1
PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells.
Identifier:nobleid.org/w1/20260515/E4DDF802
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/E4DDF802)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims